These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 28372978

  • 1. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE, Holder A, Evans-Strickfaden T, Nyagol B, Makanga M, Oyaro B, Humwa F, Williams T, McLellan-Lemal E, Desai M, Huey MJ.
    Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
    [Abstract] [Full Text] [Related]

  • 2. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
    Duijkers I, Klipping C, Heger-Mahn D, Fayad GN, Frenkl TL, Cruz SM, Korver T.
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
    [Abstract] [Full Text] [Related]

  • 3. The contraceptive vaginal ring.
    Edwardson J, Jamshidi R.
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [Abstract] [Full Text] [Related]

  • 4. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH, Dieben TO.
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [Abstract] [Full Text] [Related]

  • 5. Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ring.
    Murphy DJ, McCoy CF, Plagianos M, RamaRao S, Merkatz R, Clark H, Boyd P, Variano B, Malcolm RK.
    Contraception; 2019 Sep; 100(3):241-246. PubMed ID: 31247194
    [Abstract] [Full Text] [Related]

  • 6. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
    Barreiros FA, Guazzelli CA, Barbosa R, Torloni MR, Barbieri M, Araujo FF.
    Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg).
    Algorta J, Diaz M, de Benito R, Lefebvre M, Sicard E, Furtado M, Regidor PA, Ronchi C.
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):429-438. PubMed ID: 29336615
    [Abstract] [Full Text] [Related]

  • 8. Vaginal ring contraception.
    Kerns J, Darney P.
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [Abstract] [Full Text] [Related]

  • 9. The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
    Wagner MS, Arias RD, Nucatola DL.
    Expert Opin Pharmacother; 2007 Aug; 8(11):1769-77. PubMed ID: 17685892
    [Abstract] [Full Text] [Related]

  • 10. An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose).
    Gill K, Happel AU, Pidwell T, Mendelsohn A, Duyver M, Johnson L, Meyer L, Slack C, Strode A, Mendel E, Fynn L, Wallace M, Spiegel H, Jaspan H, Passmore JA, Hosek S, Smit D, Rinehart A, Bekker LG.
    J Int AIDS Soc; 2020 Oct; 23(10):e25626. PubMed ID: 33034421
    [Abstract] [Full Text] [Related]

  • 11. A multi-compartment vaginal ring system for independently adjustable release of contraceptive steroids.
    de Leede LG, Govers CP, de Nijs H.
    Contraception; 1986 Dec; 34(6):589-602. PubMed ID: 3829675
    [Abstract] [Full Text] [Related]

  • 12. A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.
    Kestelyn E, Agaba S, Van Nuil JI, Uwineza M, Umulisa MM, Mwambarangwe L, Ndagijimana JC, De Baetselier I, Buyze J, Delvaux T, Crucitti T, Jespers V, van de Wijgert JHHM, Ring Plus Study Group.
    PLoS One; 2018 Dec; 13(6):e0197572. PubMed ID: 29856848
    [Abstract] [Full Text] [Related]

  • 13. [Vaginal contraception: new form of administration of hormonal contraception].
    Knuist M, Hamerlynck JV.
    Ned Tijdschr Geneeskd; 2003 Oct 25; 147(43):2095-7. PubMed ID: 14619196
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
    Roumen FJ, Apter D, Mulders TM, Dieben TO.
    Hum Reprod; 2001 Mar 25; 16(3):469-75. PubMed ID: 11228213
    [Abstract] [Full Text] [Related]

  • 15. Elution from intact and broken vaginal contraceptive rings: an in vitro study.
    Regidor PA, Mueller A, Matilla S, Díez C.
    Eur Rev Med Pharmacol Sci; 2020 May 25; 24(10):5668-5675. PubMed ID: 32495902
    [Abstract] [Full Text] [Related]

  • 16. Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
    Paresi RJ, Myers RS, Matarasso A.
    Aesthet Surg J; 2015 Aug 25; 35(6):721-7. PubMed ID: 26048332
    [Abstract] [Full Text] [Related]

  • 17. Analysis and new contraception frontiers with combined vaginal rings.
    Barriga Pooley P, Von Hoveling A, Galán G, López Berroa J.
    Gynecol Endocrinol; 2020 Jun 25; 36(6):475-478. PubMed ID: 32091277
    [Abstract] [Full Text] [Related]

  • 18. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
    Roumen FJ, Dieben TO.
    Fertil Steril; 2006 Jan 25; 85(1):57-62. PubMed ID: 16412731
    [Abstract] [Full Text] [Related]

  • 19. The vaginal ring (NuvaRing®) for contraception in adolescent women.
    Bitzer J.
    Gynecol Endocrinol; 2012 Feb 25; 28(2):125-9. PubMed ID: 21615237
    [Abstract] [Full Text] [Related]

  • 20. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
    Leone Roberti Maggiore U, Remorgida V, Scala C, Tafi E, Venturini PL, Ferrero S.
    Acta Obstet Gynecol Scand; 2014 Mar 25; 93(3):239-47. PubMed ID: 24372517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.